In late August 2012, researchers announced a new discovery related to prostate cancer. For years, prostate cancer, which afflicts more than 2 million American males, was treated as though it was a single disease. However, an article in Nature Genetics revealed that scientists found a new form of prostate cancer that affects approximately 15% of those diagnosed with the condition. In this type, a mutation in the SPOP gene and subsequent loss of DNA in another area may lead to enhanced protein accumulation, which could cause tumors.

This development can lead to improved diagnosis and treatment of prostate cancer. Doctors can re-evaluate how they view the disorder by recognizing it as similar to breast and lung cancer in that it is a disease with multiple variables and subtypes. Weill Cornell Medical College’s Dr. Mark Rubin, who served as a co-senior investigator of the study, believes that by 2013, specialized tests will be designed that can identify a patient’s specific form of prostate cancer.

About the Author:

Trained in urology and surgery, Saeid Shamsian, MD, worked as a New York-based doctor for over two decades. During his career, Dr. Shamsian performed numerous cancer surgeries, particularly for individuals with prostate cancer.